Stephen Hawley Email

Senior Principal Scientist . Ansun BioPharma

Current Roles

Employees:
37
Revenue:
$5.7M
About
Ansun Biopharma is a late-stage clinical development company dedicated to saving the lives of vulnerable patient populations through the creation of first-in-class biologics. Our lead product, DAS181, is a multi-function sialidase fusion protein for host-cellprotection in respiratory virus infection, including parainfluenza, influenza and COVID19,. We are also advancing several additional programs in oncology and autoimmune diseases using our sialidase platform technology.
Ansun BioPharma Address
3030 Callan Rd.
San Diego, CA
United States
Ansun BioPharma Email

Past Companies

Ansun Biopharma, Inc.Senior Principal Scientist
NexBio, Inc.Senior Director, Drug Substance Development
NexBio, Inc.Director, Drug Substance Development

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.